Zylox Snares Over 300 Million RMB Series C Round

Zhejiang Zylox Medical Device Co. announced that it has completed the C round of financing of 300 Million RMB. This round of financing was led by Orbimed，followed by A-round investors Honghui Capital and B-round investors SDIC Innovation and Zheshang Venture Capital.

Zylox Medical Device Co. was founded in the beautiful city of Hangzhou in 2012 by a group of highly skillful and experienced returnees from the US and Europe. They have on average 5-20 years of working experiences in various functional areas such as research and development, management, and manufacturing in leading device makers including Johnson & Johnson, Medtronic, and Abbott before returning to China.

Since its inception, Zylox has developed an increasingly rich product pipeline of interventional and implantable peripheral vascular devices such as PTA balloons, PTA drug-coated Balloons (PTA DCB), superficial femoral artery (SFA) stent, drug-eluting SFA stent, and other vascular accessories. Zylox strives to continuously innovate and provide patients with superior quality medical devices.

"Neural interventional and peripheral interventional devices are currently in a period of rapid development in China, and the demand for high-quality domestic innovative products is growing rapidly. Zylox has strong R&D capabilities, numerous innovative products and complete We are in a leading position in the field of neurological and peripheral vascular interventions in China. We very much recognize the innovation and execution ability of Dr. Zhao Zhong and his team, and hope that this cooperation can help the company in Continue to maintain rapid development in the future and consolidate its leading position," said Dr. Wang Dasong, the Managing Director of Orbimed Capital.

Orbimed have been investing globally for over 20 years across the healthcare industry: from early-stage private companies to large multinational corporations. Our team of over 80 distinguished scientific, medical, investment and other professionals manages over $16 billion across public and private company investments worldwide.